Means for inhibiting the expression of CD31

Details for Australian Patent Application No. 2007241369 (hide)

Owner Silence Therapeutics AG

Inventors Kaufmann, Jorg; Keil, Oliver; Santel, Ansgar

Agent Pizzeys

Pub. Number AU-A-2007241369

PCT Pub. Number WO2007/121946

Priority 06008208.8 20.04.06 EP

Filing date 20 April 2007

Wipo publication date 1 November 2007

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

16 October 2008 PCT application entered the National Phase

  PCT publication WO2007/121946 Priority application(s): WO2007/121946

28 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007241370-Lipoplex formulations for specific delivery to vascular endothelium

2007241347-Bisadenosine compounds as adenosine A2A receptor agonists